21 CFR 211.198: Complaint files

Requires manufacturers to follow written procedures for handling written and oral drug product complaints, including quality unit review, investigation decisions, and adverse experience reporting, and to keep complaint records for at least one year past expiration.

Part 211, Current Good Manufacturing Practice for Finished Pharmaceuticals · Subpart J, Records and Reports

8%

of drug-manufacturing 483s since 2023 cite this section at least once

How FDA words it

The opening lines investigators use most when they cite 211.198, from the 483s we hold.

Procedures describing the handling of written and oral complaints related to drug products are deficiently written or followed.Most used
Procedures describing the handling of all written and oral complaints regarding a drug product are not followed.211.198(a)
Complaint records are deficient in that they do not include the findings of the investigation and follow-up.211.198(b)

Cited over time

483s citing 211.198, by year

Most citations in 2019. Bars are relative to the busiest year. *2026 to date.

Years shown: 2017 to 2026. The busiest year was 2019.

Recent 483s citing 211.198

See all 483s citing 211.198

The regulation text

§ 211.198 Complaint files.

(a)Written procedures describing the handling of all written and oral complaints regarding a drug product shall be established and followed. Such procedures shall include provisions for review by the quality control unit, of any complaint involving the possible failure of a drug product to meet any of its specifications and, for such drug products, a determination as to the need for an investigation in accordance with § 211.192. Such procedures shall include provisions for review to determine whether the complaint represents a serious and unexpected adverse drug experience which is required to be reported to the Food and Drug Administration in accordance with §§ 310.305 and 514.80 of this chapter.

(b)A written record of each complaint shall be maintained in a file designated for drug product complaints. The file regarding such drug product complaints shall be maintained at the establishment where the drug product involved was manufactured, processed, or packed, or such file may be maintained at another facility if the written records in such files are readily available for inspection at that other facility. Written records involving a drug product shall be maintained until at least 1 year after the expiration date of the drug product, or 1 year after the date that the complaint was received, whichever is longer. In the case of certain OTC drug products lacking expiration dating because they meet the criteria for exemption under § 211.137, such written records shall be maintained for 3 years after distribution of the drug product.

(1)The written record shall include the following information, where known: the name and strength of the drug product, lot number, name of complainant, nature of complaint, and reply to complainant.

(2)Where an investigation under § 211.192 is conducted, the written record shall include the findings of the investigation and followup. The record or copy of the record of the investigation shall be maintained at the establishment where the investigation occurred in accordance with § 211.180(c).

(3)Where an investigation under § 211.192 is not conducted, the written record shall include the reason that an investigation was found not to be necessary and the name of the responsible person making such a determination.

[43 FR 45077, Sept. 29, 1978, as amended at 51 FR 24479, July 3, 1986; 68 FR 15364, Mar. 31, 2003]

Questions

What does 21 CFR 211.198 require?

Requires manufacturers to follow written procedures for handling written and oral drug product complaints, including quality unit review, investigation decisions, and adverse experience reporting, and to keep complaint records for at least one year past expiration.

How often is 211.198 cited in Form 483s?

It appears in about 8% of the drug-manufacturing 483s we hold from 2023 onward.

How do FDA investigators word a 211.198 observation?

The most common opening is: “Procedures describing the handling of written and oral complaints related to drug products are deficiently written or followed.”

Which sections are cited alongside 211.198?

In the same 483s, investigators most often also cite 211.192 (Production record review), 211.22 (Responsibilities of quality control unit), 211.160 (General requirements), 211.67 (Equipment cleaning and maintenance).